Vaccines Market

A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.

Vaccines Market contains market size and forecasts of Vaccines in global, including the following market information:

Global Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Vaccines Market Sales, 2017-2022, 2023-2028, (K Pcs)

Global top five Vaccines companies in 2021 (%)

The global Vaccines market was valued at 46590 million in 2021 and is projected to reach US$ 67140 million by 2028, at a CAGR of 5.4% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Recombinant Vaccines Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Vaccines include GSK, Sanofi, Merck, Pfizer, Novartis(GSK), CSL, MedImmune LLC, J&J(Crucell) and China National Biotec, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Vaccines Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)

Global Vaccines Market Segment Percentages, by Type, 2021 (%)

Recombinant Vaccines

Viral Vaccines

Polysaccharide Vaccines

Others

Global Vaccines Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)

Global Vaccines Market Segment Percentages, by Application, 2021 (%)

Rabies vaccine

Influenza vaccine

HPV vaccine

Hepatitis B

Hepatitis A

Leprosy vaccine

Polio vaccine

JE vaccine

Others

Global Vaccines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)

Global Vaccines Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Vaccines revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Vaccines revenues share in global market, 2021 (%)

Key companies Vaccines sales in global market, 2017-2022 (Estimated), (K Pcs)

Key companies Vaccines sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

GSK

Sanofi

Merck

Pfizer

Novartis(GSK)

CSL

MedImmune LLC

J&J(Crucell)

China National Biotec

Tiantan

Hualan

Kangtai

Hissen

Jintan